Constitutively active mutant D816VKit induces megakayocyte and mast cell differentiation of early haemopoietic cells from murine foetal liver

被引:23
作者
Ferrao, PT
Gonda, TJ
Ashman, LK
机构
[1] Univ Newcastle, Fac Hlth, Sch Biomed Sci, Callaghan, NSW 2308, Australia
[2] Inst Med & Vet Sci, Hanson Ctr Canc Res, Adelaide, SA 5000, Australia
关键词
c-Kit; D816V mutation; transformation; differentiation; megakaryocyte; mast cell;
D O I
10.1016/S0145-2126(02)00272-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations of Kit at position D816 have been implicated in mastocytosis, acute myeloid leukaemia and germ cell tumours. Expression of this mutant Kit in cell lines results in factor-independent growth, differentiation and increased survival in vitro and tumourigenicity in vivo. Mutant D816VKit and wild-type Kit were expressed in murine primary haemopoietic cells and grown in stem cell factor (SCF) or the absence of factors. Expression of D816VKit did not lead to transformation as assessed by a colony assay, but resulted in enhanced differentiation of cells when compared to control cells. D816VKit induced an increase in the number of cells differentiating along the megakaryocyte lineage in the absence of factors. SCF had an added effect with an increase in differentiation of mast cells. Expression of wild-type Kit in the presence of SCF also failed to cause transformation and induced differentiation of mast cells and megakaryocytes. We conclude that constitutive expression of D816VKit in primary haemopoietic cells is not a sufficient transforming stimulus but leads to the survival and maturation of cells whose phenotype is influenced by the presence of SCF. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:547 / 555
页数:9
相关论文
共 64 条
[1]   Multilineage involvement and erythropoietin-"independent" erythroid progenitor cells in a patient with systemic mastocytosis [J].
Afonja, O ;
Amorosi, E ;
Ashman, L ;
Takeshita, K .
ANNALS OF HEMATOLOGY, 1998, 77 (04) :183-186
[2]   Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis [J].
Akin, C ;
Kirshenbaum, AS ;
Semere, T ;
Worobec, AS ;
Scott, LM ;
Metcalfe, DD .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (02) :140-147
[3]   The biology of stem cell factor and its receptor C-kit [J].
Ashman, LK .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (10) :1037-1051
[4]   Effects of mutant c-Kit in early myeloid cells (vol 34, pg 451, 1997) [J].
Ashman, LK ;
Ferrao, P ;
Cole, SR ;
Cambareri, AC .
LEUKEMIA & LYMPHOMA, 2000, 37 (1-2) :233-243
[5]  
AYLETT GCS, 1995, LEUKOCYTE TYPING, V5, P1917
[6]   C-kit mutations in core binding factor leukemias [J].
Beghini, A ;
Peterlongo, P ;
Ripamonti, CB ;
Larizza, L ;
Cairoli, R ;
Morra, E ;
Mecucci, C .
BLOOD, 2000, 95 (02) :726-727
[7]  
BRIDDELL RA, 1991, BLOOD, V78, P2854
[8]   Stem cell factor and hematopoiesis [J].
Broudy, VC .
BLOOD, 1997, 90 (04) :1345-1364
[9]   THROMBOPOIETIN (C-MPL LIGAND) ACTS SYNERGISTICALLY WITH ERYTHROPOIETIN, STEM-CELL FACTOR, AND INTERLEUKIN-11 TO ENHANCE MURINE MEGAKARYOCYTE COLONY GROWTH AND INCREASES MEGAKARYOCYTE PLOIDY IN-VITRO [J].
BROUDY, VC ;
LIN, NL ;
KAUSHANSKY, K .
BLOOD, 1995, 85 (07) :1719-1726
[10]   Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis:: A possible explanation for divergent clinical behavior [J].
Büttner, C ;
Henz, BM ;
Welker, P ;
Sepp, NT ;
Grabbe, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) :1227-1231